Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats
Authors
Keywords
-
Journal
NEUROCHEMICAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-28
DOI
10.1007/s11064-018-2638-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-7 Replacement Therapy in Parkinson’s Disease
- (2018) Ricardo Titze-de-Almeida et al. CURRENT GENE THERAPY
- Let-7a promotes microglia M2 polarization by targeting CKIP-1 following ICH
- (2018) Zhao Yang et al. IMMUNOLOGY LETTERS
- Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®
- (2018) Simoneide Titze de Almeida et al. MOLECULES
- microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches
- (2017) Loredana Leggio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease
- (2017) Karamjeet Kaur et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells
- (2017) Camila Hillesheim Horst et al. Molecular Medicine Reports
- Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo
- (2017) Kirsty J. McMillan et al. MOLECULAR THERAPY
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
- (2017) J.A. Obeso et al. MOVEMENT DISORDERS
- Animal models of α-synucleinopathy for Parkinson disease drug development
- (2017) James B. Koprich et al. NATURE REVIEWS NEUROSCIENCE
- The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
- (2017) Ricardo Titze-de-Almeida et al. PHARMACEUTICAL RESEARCH
- Old and new challenges in Parkinson's disease therapeutics
- (2017) Ana O. Pires et al. PROGRESS IN NEUROBIOLOGY
- MicroRNAs in Parkinson’s disease
- (2017) Abhishek Singh et al. EXPERIMENTAL BRAIN RESEARCH
- MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
- (2017) Ahmad R. Arshad et al. Frontiers in Molecular Neuroscience
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression
- (2016) Amrita Datta Chaudhuri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parkinson’s: a syndrome rather than a disease?
- (2016) Nataliya Titova et al. JOURNAL OF NEURAL TRANSMISSION
- Therapeutic approaches in Parkinson's disease and related disorders
- (2016) Elvira Valera et al. JOURNAL OF NEUROCHEMISTRY
- The prediagnostic phase of Parkinson's disease
- (2016) Alastair John Noyce et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Relationship of circulatory BDNF with cognitive deficits in people with Parkinson's disease
- (2016) Hanan Khalil et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
- (2016) Yan Zhou et al. Molecular Neurodegeneration
- Advances in markers of prodromal Parkinson disease
- (2016) Ronald B. Postuma et al. Nature Reviews Neurology
- Low BDNF is associated with cognitive impairments in patients with Parkinson’s disease
- (2016) Yu Wang et al. PARKINSONISM & RELATED DISORDERS
- MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression
- (2015) Savan Kabaria et al. FREE RADICAL BIOLOGY AND MEDICINE
- MicroRNA-7: A miRNA with expanding roles in development and disease
- (2015) Jessica L. Horsham et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death
- (2015) Amrita Datta Chaudhuri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-Let-7a regulates the function of microglia in inflammation
- (2015) Kyoung Joo Cho et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson’s disease model in rats
- (2014) Taysa B. Bassani et al. BRAIN RESEARCH
- Development of microRNA therapeutics is coming of age
- (2014) E. van Rooij et al. EMBO Molecular Medicine
- MicroRNA-7 Protects against 1-Methyl-4-Phenylpyridinium-Induced Cell Death by Targeting RelA
- (2014) D. C. Choi et al. JOURNAL OF NEUROSCIENCE
- Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration
- (2014) Lívia H. Morais et al. Pharmacological Reports
- Parkinson’s disease: animal models and dopaminergic cell vulnerability
- (2014) Javier Blesa et al. Frontiers in Neuroanatomy
- Involvement of MicroRNA in Microglia-Mediated Immune Response
- (2013) J. Guedes et al. Clinical & Developmental Immunology
- Tissue-specific control of brain-enriched miR-7 biogenesis
- (2013) N. R. Choudhury et al. GENES & DEVELOPMENT
- MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model
- (2013) Gina Lungu et al. NEUROSCIENCE LETTERS
- MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus
- (2012) Kai Hu et al. BMC NEUROSCIENCE
- MicroRNAs in Parkinson's disease
- (2012) M. Maral Mouradian NEUROBIOLOGY OF DISEASE
- MicroRNA-34a upregulation during seizure-induced neuronal death
- (2012) T Sano et al. Cell Death & Disease
- Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
- (2011) Kurt A. Jellinger MOVEMENT DISORDERS
- Neuroinflammation in Parkinson's disease
- (2011) Etienne C. Hirsch et al. PARKINSONISM & RELATED DISORDERS
- MicroRNAs in neurodegenerative diseases and their therapeutic potential
- (2011) Eunsung Junn et al. PHARMACOLOGY & THERAPEUTICS
- Brain Derived Neurotrophic Factor (BDNF) Expression Is Regulated by MicroRNAs miR-26a and miR-26b Allele-Specific Binding
- (2011) Viviana Caputo et al. PLoS One
- Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease
- (2011) Madalena Martins et al. PLoS One
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
- (2010) Epaminondas Doxakis JOURNAL OF BIOLOGICAL CHEMISTRY
- A highly reproducible rotenone model of Parkinson's disease
- (2009) Jason R. Cannon et al. NEUROBIOLOGY OF DISEASE
- Repression of -synuclein expression and toxicity by microRNA-7
- (2009) E. Junn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now